Suprasternal and Left Axillary Transcatheter Aortic Valve Replacement in Morbidly Obese Patients
- PMID: 30009800
- DOI: 10.1016/j.athoracsur.2018.05.095
Suprasternal and Left Axillary Transcatheter Aortic Valve Replacement in Morbidly Obese Patients
Abstract
In morbidly obese patients who cannot undergo transfemoral, transaortic, or transapical transcatheter aortic valve replacement (TAVR) due to body habitus, suprasternal (SS) and left subclavian/axillary artery (LSCLA) approaches may provide safe TAVR access. Nine morbidly obese patients with a body mass index of 35 or more underwent SS-TAVR (7 patients) or LSCLA-TAVR (2 patients) at two institutions from 2015 to 2017. Mean age was 69.4 ± 7.3 years, and mean body mass index was 50.3 ± 10.6. There were no deaths, valve reinterventions, or reoperations. Three patients required new pacemakers. In morbidly obese patients who are not candidates for the other approaches, SS-TAVR and LSCLA-TAVR allow easier vascular access and prevent the need for thoracotomy or sternotomy.
Copyright © 2018 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.
Comment in
-
Does Type of TAVR Access Affect Early Mortality in Morbidly Obese Patients?Ann Thorac Surg. 2019 May;107(5):1583-1584. doi: 10.1016/j.athoracsur.2018.07.072. Epub 2018 Sep 27. Ann Thorac Surg. 2019. PMID: 30268532 No abstract available.
-
Reply.Ann Thorac Surg. 2019 May;107(5):1584. doi: 10.1016/j.athoracsur.2018.12.031. Epub 2019 Jan 23. Ann Thorac Surg. 2019. PMID: 30684478 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
